These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 1539260)

  • 1. SK&F 105685 suppresses allogeneically induced mononuclear and endothelial cell activation and cytokine production and prolongs rat cardiac allograft survival.
    Hancock WW; Schmidbauer G; Badger AM; Kupiec-Weglinski JW
    Transplant Proc; 1992 Feb; 24(1):231-2. PubMed ID: 1539260
    [No Abstract]   [Full Text] [Related]  

  • 2. SK&F 105685: a novel immunosuppressive compound with efficacy in animal models of autoimmunity and transplantation.
    Badger AM; Albrightson-Winslow CR; Kupiec-Weglinski JW
    Transplant Proc; 1991 Feb; 23(1 Pt 1):194-5. PubMed ID: 1990512
    [No Abstract]   [Full Text] [Related]  

  • 3. Donor-type blood and immunoadjuvant-induced accelerated cardiac allograft rejection: a rat model.
    Takahara S; Jiang H; Takano Y; Kameoka H; Kokado Y; Ishibashi M; Jiang Y; Moutabarrik A; Okuyama A; Sonoda T
    Transplant Proc; 1992 Oct; 24(5):1659-60. PubMed ID: 1412787
    [No Abstract]   [Full Text] [Related]  

  • 4. Oral iron chelator desferrithiocin blocks allogeneic mononuclear cell activation and cytokine production in vivo and prolongs rat cardiac allograft survival.
    Hancock WW; Whitley D; Kupiec-Weglinski JW; Tilney NL
    Transplant Proc; 1992 Feb; 24(1):214-5. PubMed ID: 1539252
    [No Abstract]   [Full Text] [Related]  

  • 5. Induction of nonspecific x-irradiation-resistant suppressor cell activity in vivo and prolongation of vascularized allograft survival by SK&F 105685, a novel immunomodulatory azaspirane.
    Schmidbauer G; Hancock WW; Badger AM; Kupiec-Weglinski JW
    Transplantation; 1993 Jun; 55(6):1236-43. PubMed ID: 8516808
    [TBL] [Abstract][Full Text] [Related]  

  • 6. KRP-203, a novel synthetic immunosuppressant, prolongs graft survival and attenuates chronic rejection in rat skin and heart allografts.
    Shimizu H; Takahashi M; Kaneko T; Murakami T; Hakamata Y; Kudou S; Kishi T; Fukuchi K; Iwanami S; Kuriyama K; Yasue T; Enosawa S; Matsumoto K; Takeyoshi I; Morishita Y; Kobayashi E
    Circulation; 2005 Jan; 111(2):222-9. PubMed ID: 15642767
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neutrophil adhesion inhibition prolongs survival of cardiac allografts with hyperacute rejection.
    Zehr KJ; Herskowitz A; Lee PC; Poston RS; Gillinov AM; Baumgartner WA
    J Heart Lung Transplant; 1993; 12(5):837-44; discussion 844-5. PubMed ID: 8241225
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prolongation of rat major histocompatibility complex-compatible cardiac allograft survival during pregnancy.
    Funeshima-Fuji N; Fujino M; Xie L; Kimura H; Takahara S; Ezaki T; Zhu BT; Li XK
    J Heart Lung Transplant; 2009 Feb; 28(2):176-82. PubMed ID: 19201344
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Propagation and characterization of lymphocytes from transplant biopsies.
    Duquesnoy RJ; Trager JD; Zeevi A
    Crit Rev Immunol; 1991; 10(6):455-80. PubMed ID: 1830745
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prolongation of rat cardiac allograft survival by a monoclonal antibody: anti-rat intercellular adhesion molecule-1.
    Kobayashi H; Miyano T; Yamataka A; Yamataka T; Yagita H; Eto H; Ligo Y; Tansyo S; Kojima Y; Tamatani T
    Cardiovasc Surg; 1993 Oct; 1(5):577-82. PubMed ID: 7915626
    [TBL] [Abstract][Full Text] [Related]  

  • 11. SK&F 105685 treatment induces suppressor cell activity and modulates cell adhesion properties in rat recipients of cardiac allografts.
    Schmidbauer G; Hancock WW; Badger AM; Kupiec-Weglinski JW
    Transplant Proc; 1993 Feb; 25(1 Pt 1):758-60. PubMed ID: 8094912
    [No Abstract]   [Full Text] [Related]  

  • 12. Lack of preferential Th1/Th2 cytokine gene expression patterns in both alpha/beta T-cell-tolerant and -rejecting rat cardiac allografts.
    Hofmann WJ; Dufter C; Terness P; Thies J; Post S; Otto G; Otto HF; Geisse T; Gaweco AS
    Transplant Proc; 1995 Feb; 27(1):232-4. PubMed ID: 7878981
    [No Abstract]   [Full Text] [Related]  

  • 13. Prolonged survival of rat cardiac allografts induced by intrathymic injection of donor bone marrow cells.
    Matsuura T; Hara Y; Imanishi M; Kanda H; Kurita T
    Transplant Proc; 1993 Dec; 25(6):3283-5. PubMed ID: 8266544
    [No Abstract]   [Full Text] [Related]  

  • 14. Effect of hyperlipidemia and immunosuppressive drugs on cardiac allograft vascular disease in heterotopic rat cardiac transplantation.
    Hisatomi K; Isomura T; Matsuzoe S; Satou T; Hirano A; Kohjiro M
    Transplant Proc; 1996 Jun; 28(3):1958-60. PubMed ID: 8658960
    [No Abstract]   [Full Text] [Related]  

  • 15. Impact of natural killer cells and macrophages on the course of acute graft rejection following allogeneic heart transplantation in the rat.
    Dresske B; Zhu X; Peters J; Brötzmann K; Fändrich F
    Transplant Proc; 1996 Dec; 28(6):3259-60. PubMed ID: 8962264
    [No Abstract]   [Full Text] [Related]  

  • 16. Endothelial cell antigens associated with accelerated cardiac graft rejection in the rat.
    Yasunaga C; Cramer DV; Tuso PJ; Fujioka H; Barnett M; Yanaga K; Sugimachi K; Makowka L
    Transplant Proc; 1995 Feb; 27(1):495-6. PubMed ID: 7879075
    [No Abstract]   [Full Text] [Related]  

  • 17. Effect of brequinar sodium on accelerated cardiac allograft rejection in presensitized recipients.
    Nozaki S; Ito T; Kamiike W; Uchikoshi F; Yamamoto S; Nakata S; Shirakura R; Miyata M; Matsuda H; Stepkowski SM
    Transplant Proc; 1994 Aug; 26(4):2333-5. PubMed ID: 7520633
    [No Abstract]   [Full Text] [Related]  

  • 18. In vivo depletion of CD8+ T cells results in Th2 cytokine production and alternate mechanisms of allograft rejection.
    Chan SY; DeBruyne LA; Goodman RE; Eichwald EJ; Bishop DK
    Transplantation; 1995 Apr; 59(8):1155-61. PubMed ID: 7732563
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bromocriptine plus suboptimal cyclosporine treatment abrogates acute rejection of rat cardiac allografts.
    Di Stefano R; Carmellini M; Carobbi A; Vaglini F; Petrini M; Ricci F; Mosca F; Malvaldi G
    Transplant Proc; 1990 Aug; 22(4):2015-6. PubMed ID: 2389514
    [No Abstract]   [Full Text] [Related]  

  • 20. Ascorbic acid and alpha-tocopherol prolong rat cardiac allograft survival.
    Slakey D; Roza A; Pieper G; Johnson C; Adams M
    Transplant Proc; 1993 Feb; 25(1 Pt 1):610-1. PubMed ID: 8438434
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.